D3A.092
Benign carcinoid tumor of the stomach
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign carcinoid tumor of the stomach is a non-cancerous growth that originates from specialized hormone-producing cells in the stomach lining. These tumors are part of a group known as neuroendocrine tumors, which develop from cells that release hormones into the bloodstream. While benign, meaning they are not malignant, these tumors still require medical evaluation and management to monitor their growth and prevent potential complications.
Causes & Symptoms
Clinical Causes: Genetic factors or inherited conditions Chronic inflammation of the stomach lining (gastritis) Multiple endocrine neoplasia type 1 (MEN1) syndrome Long-standing atrophic gastritis Increased gastrin hormone levels (hypergastrinemia)
Key Symptoms: Often asymptomatic and discovered incidentally during endoscopy Abdominal discomfort or pain Feeling full after small meals Nausea or vomiting Bleeding in the stomach, which might lead to anemia Palpable mass in some cases Rarely, hormone-related symptoms if the tumor secretes bioactive substances
Diagnostic & Treatment
Diagnosis Path: Diagnosing a benign carcinoid tumor of the stomach typically involves several steps:
Treatment Protocols: Management of a benign carcinoid tumor of the stomach depends on its size, number, and associated conditions:
Clinical Advice & FAQs
Billing Guidance
Is D3A.092 a billable ICD-10 code?
Yes, D3A.092 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D3A.092?
Clinical documentation must specify the nature of Benign carcinoid tumor of the stomach and any associated comorbidities for accurate reporting.
Cite this Clinical Reference